Eurofins Central Laboratory
Michael Koratich has over 20 years of industry-leading global scientific expertise in the biologics' clinical trials field. Michael has held various roles including Senior Director at Eurofins Bioanalytical Services, VP of Pharma Services at Flagship Biosciences, and Associate Director at Southern Research. Michael has experience in business development, strategic planning, marketing, and revenue generation. Michael also has a background in sales, particularly in launching and promoting pharmaceutical products. Additionally, they have worked as an Adjunct Faculty at Jefferson State Community College. Currently, Michael is serving as the VP of Integrated Laboratory Services at Eurofins Central Laboratory.
Michael Koratich has a Bachelor of Science (BS) and Master of Science (MS) degree in Biology from PennWest California. In addition to their academic qualifications, they obtained certifications in Customer Service: Problem Solving and Troubleshooting, Learning LinkedIn Sales Navigator, and Business Development: Strategic Planning from LinkedIn. The certifications were obtained in July and August of 2021.
This person is not in any offices
Eurofins Central Laboratory
Eurofins Central Laboratory is a global organization fully focused and dedicated to providing standardized, high quality global central laboratory services to support all phases of clinical trials. Eurofins Central Laboratory supports its customers with 4 wholly-owned and harmonized laboratory facilities located in the US, Europe, Singapore and China. With 25+ years of experience and scientific accomplishment, its laboratory testing portfolio has become one of the widest available in the biopharmaceutical industry and offers the synergy of integrated safety assessment, exploratory biomarkers, end point biomarkers, biomarker development, therapeutic drug monitoring, genomic testing and a full range of services to support vaccine development. Eurofins Central Laboratory provides the highest quality central laboratory services, accurate, timely results capturing the planned completion date, and expert advice from their highly qualified team of experienced scientists.